Established in 2012, Accretion Pharmaceuticals Limited is a Gujarat-based pharmaceutical company engaged in manufacturing and marketing a diverse range of healthcare products, including tablets, capsules, oral liquids, external preparations (ointments, creams, gels, lotions, medicated shampoos, mouthwashes, and dusting powders), and oral powders (sachets and dry syrups).

The company also provides contract manufacturing services from its ISO-certified (9001:2015, 14001:2015, and 22000:2005) facility in Ahmedabad, Sanand, demonstrating its commitment to quality and environmental standards. With a growing global presence, the company exports to over 20 countries across Africa, Southeast Asia, and the Middle East.

Accretion Pharmaceuticals boasts a robust product portfolio, covering antibiotics, anti-inflammatory drugs, pain management solutions, cardiovascular and gastrointestinal medicines, pediatric syrups, respiratory treatments, dermatological products, and Ayurvedic/herbal wellness solutions. As of January 2025, the company employs 83 professionals, including four Executive Directors.

The company’s IPO will open for subscription from May 14 to May 16, 2025, with a price band of ₹96 to ₹101 per share. The allocation is divided into 35% for retail investors, 50% for QIBs, and 15% for HNIs. The share allotment will be finalized on May 19, 2025, and the stock is set to list on the NSE on May 21, 2025. Financially, the company has shown strong growth, with revenue increasing to ₹33.94 crores in 2024 from ₹29.53 crores in 2023, while profits surged significantly to ₹3.88 crores from just ₹0.10 crores in the same period.

Accretion Pharmaceuticals IPO Details

IPO Date	May 14, 2025 to May 16, 2025
Listing Date	[.]
Face Value	₹10 per share
Issue Price	₹96 to ₹101 per share
Lot Size	1,200 Shares
Total Issue Size	Approx ₹29.75 Crores
Fresh Issue	Approx ₹29.75 Crores
Issue Type	Book Built IPO
Listing At	NSE SME
Share Holding Pre Issue	81,70,000 shares
Share Holding Post Issue	1,11,16,000 shares

Accretion Pharmaceuticals IPO Dates

The initial public offering (IPO) of Accretion Pharmaceuticals will be available for subscription from May 14, 2025 to May 16, 2025.

IPO Open Date	Wed, May 14, 2025
IPO Close Date	Fri, May 16, 2025
Tentative Allotment	Mon, May 19, 2025
Refunds	Tue, May 20, 2025
Credit of Shares to Demat	Tue, May 20, 2025
IPO Listing Date	Wed, May 21, 2025
UPI Mandate Confirmation Deadline	5 PM on May 16, 2025

Accretion Pharmaceuticals IPO Market Lot

The minimum investment for Accretion Pharmaceuticals IPO is ₹121,200, equivalent to 1,200 shares per market lot.

Application	Lot Size	Shares	Amount
Retail Minimum	1	1200	₹1,21,200
Retail Maximum	1	1200	₹1,21,200
S-HNI Minimum	2	2,400	₹2,42,400

Know more

Accretion Pharmaceuticals IPO: Should You Buy In?